Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993, 178: 2243-7. 10.1084/jem.178.6.2243.
Article
CAS
PubMed
Google Scholar
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR: An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993, 178: 2249-54. 10.1084/jem.178.6.2249.
Article
CAS
PubMed
Google Scholar
Ottenhoff TH, De Boer T, van Dissel JT, Verreck FA: Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv Exp Med Biol. 2003, 531: 279-94.
Article
CAS
PubMed
Google Scholar
Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-76. 10.1016/S1473-3099(04)01206-X.
Article
CAS
PubMed
Google Scholar
Jacobs M, Togbe D, Fremond C, Samarina A, Allie N, Botha T, Carlos D, Parida SK, Grivennikov S, Nedospasov S, et al.,: Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect. 2007, 9: 623-8. 10.1016/j.micinf.2007.02.002.
Article
CAS
PubMed
Google Scholar
Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, et al.,: IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007, 8: 369-77. 10.1038/ni1449.
Article
CAS
PubMed
Google Scholar
Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F: Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis. 2006, 194: 984-92. 10.1086/507427.
Article
CAS
PubMed
Google Scholar
Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, Kou Z, Wang Q, Jiang L, Estep J, et al.,: Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science. 2002, 295: 2255-8. 10.1126/science.1068819.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cohen NR, Garg S, Brenner MB: Antigen Presentation by CD1 Lipids, Cells T, and NKT Cells in Microbial Immunity. Adv Immunol. 2009, 102: 1-94. full_text.
Article
CAS
PubMed
Google Scholar
Cooper AM: T cells in mycobacterial infection and disease. Curr Opin Immunol. 2009, 21: 378-84. 10.1016/j.coi.2009.06.004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rook GA: Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med. 2007, 7: 327-37. 10.2174/156652407780598557.
Article
CAS
PubMed
Google Scholar
Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK: FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med. 2009, 179: 1061-70. 10.1164/rccm.200804-529OC.
Article
CAS
PubMed
Google Scholar
Hart PD, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J. 1977, 2: 293-5. 10.1136/bmj.2.6082.293.
Article
PubMed Central
CAS
PubMed
Google Scholar
Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, et al.,: BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002, 359: 1393-401. 10.1016/S0140-6736(02)08353-8.
Article
PubMed
Google Scholar
Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, Vanini V, Girardi E, Goletti D, D'Amelio D, et al.,: Detection of IL-2 in addition to IFN-gamma discriminates active tuberculosis patients, latently infected individuals and controls. Clin Microbiol Infect. 2009,
Google Scholar
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001, 345: 1098-104. 10.1056/NEJMoa011110.
Article
CAS
PubMed
Google Scholar
Soares AP, Scriba TJ, Joseph S, Harbacheuski R, Murray RA, Gelderbloem SJ, Hawkridge A, Hussey GD, Maecker H, Kaplan G, et al.,: Bacillus calmette-guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol. 2008, 180: 3569-77.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lalor MK, Smith SG, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, Branson K, Fine PE, Dockrell HM: Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine. 2010, 28: 1635-41. 10.1016/j.vaccine.2009.11.004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Beveridge NE, Price DA, Casazza JP, Pathan AA, Sander CR, Asher TE, Ambrozak DR, Precopio ML, Scheinberg P, Alder NC, et al.,: Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol. 2007, 37: 3089-100. 10.1002/eji.200737504.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ottenhoff TH, Kumararatne D, Casanova JL: Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today. 1998, 19: 491-4. 10.1016/S0167-5699(98)01321-8.
Article
CAS
PubMed
Google Scholar
Flynn JL, Chan J: Immunology of tuberculosis. Annu Rev Immunol. 2001, 19: 93-129. 10.1146/annurev.immunol.19.1.93.
Article
CAS
PubMed
Google Scholar
Stenger S: Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis. 2005, 64 (Suppl 4): iv24-8. 10.1136/ard.2005.042531.
PubMed Central
CAS
PubMed
Google Scholar
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999, 401: 708-12. 10.1038/44385.
Article
CAS
PubMed
Google Scholar
Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003, 171: 6173-7.
Article
CAS
PubMed
Google Scholar
Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001, 108: 430-8. 10.1067/mai.2001.117929.
Article
CAS
PubMed
Google Scholar
Lockhart E, Green AM, Flynn JL: IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006, 177: 4662-9.
Article
CAS
PubMed
Google Scholar
Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y, et al.,: IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol. 2007, 178: 3786-96.
Article
CAS
PubMed
Google Scholar
Smith SM, Malin AS, Pauline T, Lukey , Atkinson SE, Content J, Huygen K, Dockrell HM: Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun. 1999, 67: 5223-30.
PubMed Central
CAS
PubMed
Google Scholar
Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G, Hassan HY, Wilkinson RJ, Walzl G, Gelderbloem SJ, et al.,: Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol. 2008, 180: 1962-70.
Article
PubMed Central
CAS
PubMed
Google Scholar
Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007, 8: 639-46. 10.1038/ni1467.
Article
CAS
PubMed
Google Scholar
Seder RA, Darrah PA, Roederer M: T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008, 8: 247-58. 10.1038/nri2274.
Article
CAS
PubMed
Google Scholar
McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV: Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med. 2004, 10: 1240-4. 10.1038/nm1128.
Article
CAS
PubMed
Google Scholar
Garcia-Pineres A, Hildesheim A, Dodd L, Kemp TJ, Williams M, Harro C, Lowy DR, Schiller JT, Pinto LA: Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles. Clin Vaccine Immunol. 2007, 14: 984-9. 10.1128/CVI.00090-07.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pinto LA, Castle PE, Roden RB, Harro CD, Lowy DR, Schiller JT, Wallace D, Williams M, Kopp W, Frazer IH, et al.,: HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine. 2005, 23: 3555-64. 10.1016/j.vaccine.2005.01.146.
Article
CAS
PubMed
Google Scholar